The effect of adding nebulized low molecular weight heparin to the treatment of outpatients with Covid 19

Phase 3

Recruiting

• Conditions: Covid-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20231008059655N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Positive Covid-19 test
Patients who are treated on an outpatient basis

Exclusion Criteria

Patients with poor general condition and hospitalization in the emergency room
Patients with acute medical problems

Study & Design

• Study Type: interventional
• Study Design: Not specified